Sarcopenia, defined by computed tomography (CT) measurements of muscle mass, is a valuable method for objectively staging frailty preoperatively. However, prior analyses have focused on psoas sarcopenia, which has not been validated in patients with chronic thoracic aortic disease. We hypothesized that thoracic sarcopenia is common in this patient population, and is more accurate than psoas sarcopenia in predicting long-term survival after thoracic endovascular aortic repair (TEVAR).
Methods: An independent post hoc analysis was conducted of three prospective trials of the conformable GORE TAG device (W. L. Gore & Associates, Inc., Newark, Del) for patients undergoing TEVAR for thoracic aortic injury, dissection, or aneurysm; the latter two groups were classified as having chronic aortic disease. Patients with preoperative CT imaging were included. Using a novel automated sequence, thoracic sarcopenia was assessed by measuring total area of the rectus abdominis, latissimus dorsi, intercostal, erector spinae, and external and internal oblique muscles at the T12 level. The L3 psoas area was used to define abdominal sarcopenia using a standard method. For each measurement method, patients were compared by sarcopenia status. The primary outcome was 2-year mortality assessed by log-rank test. Injured patients were used as a comparison group without chronic aortic disease. Significance was set at P < .05.
Results: Overall, 154 patients (aneurysm, 39; dissection, 67; injury, 49) had preoperative imaging enabling measurement of thoracic and abdominal sarcopenia. Among chronic aortic disease patients, thoracic and abdominal sarcopenia occurred in 37% and 35% (81% agreement). Sarcopenic patients were older, had lower body mass indices, and were more frequently male and white; comorbidities and procedural characteristics were similar between patient groups. Whereas abdominal sarcopenia did not predict mortality at any time point (Fig 1; 2-year mortality, 16% vs 15%; P ¼ .66), T12 sarcopenia was associated with substantially higher long-term mortality (Fig 2; 2-year mortality 23% vs 10%; P < .05). In contrast, among injured patients, thoracic sarcopenia was less frequent (15%), and was not associated with increased mortality (0% vs 15%; P ¼ .58).
Conclusions: Thoracic sarcopenia is common among patients with chronic aortic disease, and is an important and specific predictor of long-term mortality after TEVAR. In contrast, psoas-derived assessment of sarcopenia may not be valid in this patient population. As an objective, reproducible, and patient-specific indicator of frailty, T12 sarcopenia may provide for valuable risk assessment to optimize appropriate patient selection for TEVAR and to identify patients at greater risk for late adverse outcomes. 83 and OR, 1.64; 95% CI, 1.54-1.74, respectively). As expected, diagnostic procedures had the lowest rate of FPA (0.22%) compared with angioplasty (0.39%) or stent placement (0.33%; P < .0001). Surprisingly, patients with elective admission were 1.22 times as likely to have FPA (95% CI, 1.19-1.25) than those with nonelective hospitalization. Interestingly, patients in urban hospitals had the highest incidence of FPA (0.30% in urban teaching and 0.28% in urban nonteaching vs 0.20% in rural hospitals; P < .0001). Compared with the Northeast region, FPA incidence was greater in the West (OR, 1.12; 95% CI, 1.08-1.16) and highest in the Midwest and South regions (OR, 1.24; 95% CI, 1.20-1.28 for both). FPA resulted in a significant increase in duration of stay, from 3 days (IQR, 1-6 days) to 5 days (IQR, 3-9 days; P < .001), and resulted in a 30% increase in total cost of hospitalization, from $15,651 (IQR, $10,102-$24,967) to $22,347 (IQR, $15, 030) .
Conclusions: FPA after coronary procedures is a significant complication, resulting in unacceptable increases in both hospital duration of stay and total cost. With the incidence of FPA increasing, urgent attention and further root cause analysis is indicated to reduce this adverse trend in patient outcomes.
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Methods: The Vascular Quality Initiative was reviewed for all elective open abdominal aortic aneurysm (AAA) repairs and lower extremity bypass (LEB) in patients with a smoking history from 2010 to 2017. Three groups were identified those who had long-term smoking cessation (LTSC; quit smoking >8 weeks before operation), those who had shortterm smoking cessation (STSC; quit <8 weeks before operation), and those currently smoking (CS). Patient and case details were recorded.
Multivariable analysis was used to analyze outcomes.
Results: We identified 5215 elective AAA (42.9% LTSC, 2.4% STSC, 54.7% CS) and 17,403 elective LEB (42.5% LTSC, 2.2% STSC, 54.8% CS). For AAA, STSC were more often younger, male, obese, have less chronic obstructive pulmonary disease (COPD) and diabetes, and more likely to be on a statin than CS (P < .05 for all). There was no difference in proximal aneurysm extent or approach. LTSC was associated with lower perioperative pulmonary complications (OR, 0.65; 95% CI, 0.53-0.79; P < .001), but this was not seen in STSC (OR, 0.52; 95% CI, 0.25-1.08; P < .081). There were no differences in cardiac, wound, leg or bowel ischemia, return to the operating room, or perioperative mortality based on smoking status. For LEB, STSC compared with CS were more often female, obese, nonCaucasian, diabetic, and had less coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and more likely to be on an aspirin and a statin (P < .05 for all). LTSC and STSC were not associated with lower perioperative complications after LEB including pulmonary, stroke, wound, return to the operating room, or mortality. 
